Molecular Partners reports phase 1 data for cancer drug MP0317
- ByInvesting.com•
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 147.85 | 149.30 | 145.30 | -0.65 | -0.44% | 214.12K | ||
| 78.66 | 79.72 | 78.24 | +0.22 | +0.28% | 1.13M | ||
| 71.32 | 73.30 | 71.12 | -1.16 | -1.60% | 267.39K | ||
| 79.44 | 80.04 | 77.66 | +2.70 | +3.52% | 357.79K | ||
| 538.00 | 544.60 | 534.40 | -5.80 | -1.07% | 108.93K | ||
| 902.20 | 919.40 | 899.60 | -14.60 | -1.59% | 28.62K | ||
| 114.00 | 116.06 | 113.74 | -1.90 | -1.64% | 783.26K | ||
| 78.42 | 79.85 | 78.25 | -0.63 | -0.80% | 1.23M | ||
| 125.05 | 126.35 | 124.25 | -0.90 | -0.71% | 364.69K | ||
| 317.00 | 319.60 | 316.10 | -1.40 | -0.44% | 189.31K | ||
| 478.80 | 484.20 | 471.60 | -0.40 | -0.08% | 117.22K | ||
| 656.50 | 662.50 | 655.50 | -5.00 | -0.76% | 23.54K | ||
| 522.60 | 532.60 | 518.00 | -4.60 | -0.87% | 51.08K | ||
| 144.30 | 145.10 | 142.15 | +0.60 | +0.42% | 150.63K | ||
| 875.80 | 878.00 | 857.80 | +27.80 | +3.28% | 54.81K | ||
| 177.80 | 184.05 | 177.05 | -4.90 | -2.68% | 140.08K | ||
| 34.14 | 34.74 | 33.95 | -0.36 | -1.04% | 2.24M | ||
| 2,790.00 | 2,816.00 | 2,779.00 | +5.00 | +0.18% | 4.34K | ||
| 58.24 | 58.54 | 57.64 | +0.02 | +0.03% | 215.1K | ||
| 41.60 | 42.86 | 41.15 | -1.16 | -2.71% | 546.14K |
No Earning Reports have been scheduled